Streetbeat News

Regulatory

CABA

CLCO

FTCH

LESL

LVS

OKTA

PHG

VERV

Leslie's, Inc. reported mixed Q4 results with revenue exceeding estimates but earnings per share falling short, causing a 15% pre-market drop. Verve Therapeutics announced a public offering and private placement, leading to an 11.2% pre-market decline. Cabaletta Bio continued to fall after FDA concerns over CAR T cell therapies. Okta disclosed a data breach affecting all support system users. Cool Company reported Q3 results, contributing to a pre-market dip. Las Vegas Sands announced a stock offering by its principal stockholder. Philips faced FDA safety concerns with its CPAP machines. Farfetch delayed its Q3 financial results announcement.

Portfolio Pulse from Lisa Levin

November 29, 2023 | 10:48 am

CRM

GOOG

GOOGL

MSFT

AI researcher Timnit Gebru has rejected the idea of joining the OpenAI board, stating she finds it 'repulsive' and would rather consider returning to Google, which she left in 2020. OpenAI, backed by Microsoft, has faced criticism for its board's lack of diversity and has plans to expand it. Gebru's comments come after Sam Altman's return as CEO of OpenAI and amidst concerns over AI safety and diversity within the company.

Portfolio Pulse from Rounak Jain

November 29, 2023 | 10:28 am

TSLA

Hota Industrial Mfg. Co, a Taiwanese supplier for Tesla Inc. (NASDAQ:TSLA), is establishing its first U.S. factory in New Mexico to reduce shipping costs and mitigate cross-strait tensions. The $99 million investment aims to enhance supply chain security and proximity to North American customers, which make up 70% of Hota's sales. The New Mexico government is supporting the project with $3 million and potential tax credits. Hota expects to benefit from the U.S. Inflation Reduction Act, with production starting in 2025.

Portfolio Pulse from Benzinga Neuro

November 29, 2023 | 9:57 am

PHO

Photocure ASA's partner Asieris Pharmaceuticals has announced that China's National Medical Products Administration (NMPA) has accepted the new drug application for Hexvix, a bladder cancer detection drug. Hexvix was licensed to Asieris by Photocure for commercialization in mainland China and Taiwan.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 9:32 am

BTCUSD

Robert Kiyosaki, author of 'Rich Dad Poor Dad', recommends buying a Bitcoin ETF, citing a potential economic depression and the likelihood of the Treasury and Fed printing more money. He suggests investing in gold, silver, and Bitcoin, with a particular emphasis on the affordability of silver and the opportunity to invest in a Bitcoin ETF. Financial analysts note that several asset management companies, including BlackRock, WisdomTree, and Valkyrie, await SEC approval for a spot Bitcoin ETF.

Portfolio Pulse from Mehab Qureshi

November 29, 2023 | 8:55 am

GGR

Gogoro, a company specializing in electric vehicles and battery swapping, has been recognized by the Small Industries Development Bank of India (SIDBI), making certain Gogoro vehicles eligible for SIDBI's financial programs aimed at boosting electric vehicle (EV) penetration in India. SIDBI is a key financial institution established in 1990 to support the development of Micro, Small, and Medium Enterprises (MSME) in India.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 7:39 am

IONM

Assure Holdings has received a non-compliance notice from Nasdaq because it failed to file its 10-Q report on time. The company has until January 22, 2024, to submit a plan to regain compliance with Nasdaq's listing rules. The notice does not currently affect the trading of the company's stock on the Nasdaq Capital Market.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 6:38 am

OMEX

Odyssey Marine Exploration, Inc. received a non-compliance notice from Nasdaq due to a delay in filing its Form 10-Q. The company intends to file the required form with the SEC promptly to regain compliance with Nasdaq Rule 5250(c)(1).

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 6:23 am

General Motors Co (GM) is reportedly reducing funding for its self-driving unit, Cruise, following a pedestrian injury incident. This decision may impact GM's long-term revenue targets, which include income from self-driving technology. Cruise has faced safety concerns and regulatory challenges, leading to a suspension of operations. Despite a recent EBIT-adjusted loss, Cruise plans to relaunch operations in one city to rebuild trust and scale up gradually.

Portfolio Pulse from Anan Ashraf

November 29, 2023 | 3:33 am

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrencies Bitcoin (BTC), Ethereum (ETH), and Dogecoin (DOGE) rose after Federal Reserve Governor Chris Waller's dovish remarks, suggesting a potential for rate cuts if inflation continues to decline. Waller's comments, indicating a moderating economic pace and favorable inflation trends, have fueled optimism in the markets, leading to a rise in stocks and a dip in U.S. Treasury yields. Analysts predict a 'Santa Claus Rally' that may push Bitcoin beyond $40K, while on-chain data shows profit-taking in Bitcoin and an increase in Dogecoin wallets.

Portfolio Pulse from Mehab Qureshi

November 29, 2023 | 2:58 am